Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05681078 · ClinicalTrials.gov registry record · NA

The Impact of Hearing Loss Severity on Balance Intervention Outcomes

A NA study of Hearing Loss and Fall, sponsored by University of Arkansas.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT05681078: Completed NA study of Hearing Loss and Fall, sponsored by University of Arkansas.

NCT05681078 is a NA study of Hearing Loss and Fall that has completed, run by University of Arkansas. The registered enrollment target is 29 participants, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05681078, a NA study of Hearing Loss and Fall, has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to learn about how hearing loss impacts balance intervention outcomes and risk of falling in older adults. The main questions it aims to answer are: * How does the evidence-based A Matter of Balance (AMOB) program affect older adults' falls risk and balance-related measures? * Is the severity of someone's hearing loss related to their balance intervention (AMOB) outcomes? Participants will: * Complete a hearing and balance test * Answer some questions about their background and health history, their thoughts about potential falls and how this impacts them, and their current physical activity level * Participate in the A Matter of Balance Program, an evidence-based program that includes group discussion, activities, and exercises to reduce fall risk

Primary Outcome

Postural sway will be assessed using a Balance Tracking Systems pressure plate.

Interventions

  • BEHAVIORAL A Matter of Balance: Managing Concerns about Falls

Study Locations (1)

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2023-02-08
Est. Completion 2023-09-15
Phase NA
University of Arkansas

318 total trials

What the finished NCT05681078 record still lists

NCT05681078 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which A Matter of Balance: Managing Concerns about Falls is the first listed.

NCT05681078 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT05681078 about?

NCT05681078 is a clinical study titled "The Impact of Hearing Loss Severity on Balance Intervention Outcomes". The goal of this study is to learn about how hearing loss impacts balance intervention outcomes and risk of falling in older adults. The main questions it aims to answer are: * How does the evidence-based A Matter of Balance (AMOB) program affect older adults' falls risk and balance-related measure...

What is the current status of trial NCT05681078?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2023-02-08. Estimated completion is 2023-09-15.

What conditions does trial NCT05681078 study?

This clinical trial studies the following conditions: Hearing Loss, Fall, Postural Balance.

What interventions are being tested in trial NCT05681078?

The interventions under investigation include: A Matter of Balance: Managing Concerns about Falls (BEHAVIORAL).

Who is sponsoring clinical trial NCT05681078?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05681078 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05681078's enrollment target sits among peer trials

29 51st of 58 higher than 8 of 58 other Hearing Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05681078, the US trial registry maintained by the National Library of Medicine. NCT05681078 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.